Daniel

[Shyamali C Dharmage @CDharmage]

Lets promote and advance the field of pre-COPD. Recognising and tackling the pre-disease and early disease states have helped reducing the burden of many chronic diseases, so why not in COPD? https://t.co/Jn1DrYTpV5

[Shyamali C Dharmage @CDharmage]

Grateful to @LancetRespirMed for the kind profile. Honoured and humbled to be featured. Thank you.
Shyamali Dharmage: mapping lung health trajectories across the life course - The Lancet Respiratory Medicine https://t.co/v9tQDJYk7o

[Surya P Bhatt, MD, MSPH @suryapbhatt]

1/2 New pub in @JAMA_current from #CLAIR! New Diagnostic Schema for #COPD 15.4%⬆️COPD among smokers; 6.4%⬇️ diagnosis among airflow obstruction but no symptoms/imaging findings. Newly detected have high risk of mortality, exacerbations and FEV1 decline https://t.co/p0CE6rgaYk

[ATS Blue Journal @ATSBlueEditor]

Temporal Exploration of COPD Phenotypes: Insights from the COPDGene and SPIROMICS Cohorts

The authors present a method that phenotypes and models disease trajectories in a large population of COPD patients
@meilan_han
@umichmedicine
@andrei_zinovyev

https://t.co/JEF8WN2PiA

[NEJM @NEJM]

A new review discusses challenges and pitfalls in the diagnosis and management of chronic cough that is unexplained after a complete evaluation or that is refractory to treatment for identified causes.

Read the Review Article “Unexplained or Refractory Chronic Cough in Adults” by Richard S. Irwin, MD, and J. Mark Madison, MD, from @umasschan: https://t.co/yXHA1Tuzvy

[Respirology @RespirologyAPSR]

🌏Respirology
"Building Respirology" - a 'looking back' Editorial by outgoing Co-Editor in Chief Prof Philip Bardin in #Respirology

#FreeAccess
https://t.co/RpDDVedcGe
@PhilBardin @APSRapsr

[NEJM @NEJM]

Original Article: Long-Term Oxygen Therapy for 24 or 15 Hours per Day in Severe Hypoxemia (REDOX) https://t.co/2oWyc6lRHC

Editorial: Making Long-Term Oxygen Therapy Less Burdensome https://t.co/vtxuKCED1W

#ERSCongress | @EuroRespSoc

[Erik Melén @ErikMelen]

👇👇
Grateful for this @EuroRespSoc CADSET collaboration paper - such a wonderful teamwork! 🙏 First author Dr Hernandez-Pacheco - big congrats!

[Shyamali C Dharmage @CDharmage]

Pre-COPD is here to stay until we find solutions-let’s work together to solve this novel paradigm

[NEJM @NEJM]

Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/sAyCiZkZLH

Editorial: Entering a New Era in Sleep-Apnea Treatment https://t.co/uu5ImeLA3k

#ADASciSessions

[ATS Blue Journal @ATSBlueEditor]

Can We Use Lung Function Thresholds and Respiratory Symptoms to Identify Pre-Chronic Obstructive Pulmonary Disease?

Pre-bronchodilator FEV1/FVC at the 10th percentile identifies those at risk of developing COPD in community settings

🔗 https://t.co/ysZqTOdcIP

[Daniel @DanielJ_Tan]

Excited to see our work published in the Blue Journal - many thanks to my supervisors @CDharmage, @Perret777 and Caroline Lodge

[ATS Blue Journal @ATSBlueEditor]

The Blue Journal thanks Daniel Tan for his contribution to the June 15 issue

Can We Use Lung Function Thresholds and Respiratory Symptoms to Identify Pre-Chronic Obstructive Pulmonary Disease?
@DanielJ_Tan

https://t.co/DbUp2UEY19

[Daniel @DanielJ_Tan]

UCAP demonstrates clinical benefit of screening and early treatment of obstructive airways diseases.

[NEJM @NEJM]

Presented at #ATS2024:

UCAP trial: Case finding for symptomatic adults with undiagnosed asthma or COPD was coupled with a randomized trial to compare pulmonologist-directed and usual care. Pulmonologist-directed care led to less health care utilization. https://t.co/y8On3u8uw1

[NEJM @NEJM]

Presented at #ATS2024:

A study assessed the clinical, occupational, and financial effects associated with changing from race-based to race-neutral equations for the interpretation of lung function on millions of patients. Full study results: https://t.co/uQ83ohdbbd

[Shyamali C Dharmage @CDharmage]

This is such an exciting project. Hope we can find ways to arrest or slow the progression pre-COPD to #COPD @meilan_han

[Kirsten Bibbins-Domingo @KBibbinsDomingo]

A pleasure to join JAMA Statistical Editor Issa Dahabreh @CAUSALab @HarvardChanSPH in writing on a framework medical journals might use to approach causal inference from observational studies

Read the Special Communications below & accompanying editorial https://t.co/6k2LMnltej

[ThoraxBMJ @ThoraxBMJ]

Interstitial lung disease.
Rheumatoid arthritis and idiopathic pulmonary fibrosis: a bidirectional Mendelian randomisation study https://t.co/sf01iQRj8a @Liv_leavy @leticiakawano

[ALHU @ALHU_MSPGH]

A tribute to the 6th anniversary of the extraordinary #TAHS study by Dr Dinh Bui at #TSANZSRS2024

[Daniel @DanielJ_Tan]

@ALHU_MSPGH @JingwenZ6 @tsanz_thoracic Congrats Jingwen!

[ThoraxBMJ @ThoraxBMJ]

For most people, lung function trajectories are established early in childhood. Asthma and airways hyper-responsiveness are associated with life course-persistent adverse trajectories. https://t.co/QltGYx3XLO